{"filings":[{"id":452676,"accession_number":"0001628280-26-035318","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2026-05-15T11:55:30+00:00","items":["5.02","5.07","7.01","9.01"],"status":"ready","headline":"Quaker Houghton names Mark Douglas Chairman; Michael Barry retires after 18 years","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael F. Barry retired as Chairman and director on May 13, 2026 after 18 years on Board, 17 as Chairman.","Board reduced size from 11 to 10 directors; eliminated Lead Director role as new Chairman Mark Douglas is independent.","Mark A. Douglas, director since 2013 and former CEO of a global chemical company, elected Chairman.","Barry's retirement voluntary; no disagreement; company cited ~30 acquisitions under his tenure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99011,"accession_number":"0001628280-26-028945","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q1 net sales up 8% to $480.5M; non-GAAP EPS $1.63, up 3% Y/Y","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $480.5M (+8% Y/Y); organic volumes up 3% driven by ~4% new business wins.","GAAP diluted EPS $1.13 (net income $19.7M) vs $0.73; non-GAAP diluted EPS $1.63 vs $1.58.","Adjusted EBITDA $72.5M (+5% Y/Y); segment earnings up in EMEA and Asia/Pacific, down in Americas.","Amended credit agreement extends nearest maturity to 2031; new cost program targets $20-30M savings by 2028.","Expects raw material inflation in Q2, temporary margin impact; reaffirms 2026 revenue/EBITDA growth barring end-market deterioration."],"consensus_eps_estimate":null,"consensus_eps_actual":1.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":480479000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99010,"accession_number":"0001628280-26-025084","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Quaker Chemical Amends Credit Agreement, Secures $1.6B in New Facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered into Amendment No. 4 to credit agreement on April 10, 2026, with $550M U.S. term loan, $250M euro term loan, and $800M revolving credit facility.","Proceeds used to repay all outstanding loans under existing credit agreement and to fund strategic growth and capital allocation priorities.","Maturity extended to April 10, 2031; nearest debt maturity now 2031, improving credit terms and liquidity.","Financial covenants include Consolidated Net Leverage Ratio not greater than 4.25x and Consolidated Interest Coverage Ratio test.","Dividend flexibility: regularly scheduled payments up to $30M per fiscal year, with additional capacity under leverage ratio thresholds."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114792,"accession_number":"0001104659-26-027045","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Quaker Houghton SVP & Chief Global Operations Officer Jeff Fleck Departs Involuntarily","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeffrey Fleck no longer serves as SVP, Chief Global Operations Officer effective March 9, 2026.","Termination is involuntary without cause; no disagreement between Fleck and the company.","Fleck eligible for severance benefits per employment agreement and company plans subject to release.","No successor named; role appears vacant pending further action."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114791,"accession_number":"0001628280-26-010689","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton reports Q4 net sales $468.5M (+6% Y/Y); FY2025 net loss $2.5M due to impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $20.7M ($1.18 diluted EPS); non-GAAP EPS $1.65, up 24% Y/Y.","Full year net sales $1.89B; net loss $2.5M ($0.14 loss per share) includes $88.8M impairment and $35.1M restructuring.","Adjusted EBITDA Q4 $71.9M (+11% Y/Y); full year $299.2M.","Asia/Pacific segment net sales up 15% in Q4; Americas flat, EMEA up 7%.","Generated $136.5M operating cash flow in 2025; returned $75.9M to shareholders via dividends and buybacks."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":1888634000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131168,"accession_number":"0001628280-25-047569","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q3 net sales +7% to $493.8M; adj. EPS $2.08 (+10% YoY); leverage reduced to 2.4x","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $493.8M (+7% YoY) driven by organic volume +3% and acquisitions +5%; price/mix -2%.","GAAP EPS $1.75; non-GAAP EPS $2.08 (+10% YoY); adjusted EBITDA $82.9M (margin 16.8%).","Operating cash flow YTD $89.9M (vs $141.5M); gross debt reduced $61.5M in Q3; share repurchases $3.8M.","Asia/Pacific sales +18% YoY (organic volume +8%); Americas +1%; EMEA +7%.","CEO expects Q4 YoY sales and earnings growth despite soft demand; building momentum for 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":1420156000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147749,"accession_number":"0000081362-25-000118","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton reports Q2 net loss of $66.6M on $88.8M impairment; adjusted EPS $1.71 vs $2.13","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $483.4M (+4% Y/Y); organic volumes +2% on new business wins of ~5%.","Net loss $66.6M ($3.78 loss/share) includes $88.8M goodwill impairment in EMEA segment.","Non-GAAP net income $30.0M, EPS $1.71, down from $2.13; adjusted EBITDA $75.5M (-10%).","Asia/Pacific net sales +20% (8% volume growth); Americas -1%, EMEA +1%.","Repurchased $32.7M shares; dividend raised ~5%; expects FY 2025 results in range of 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":926314000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147748,"accession_number":"0001104659-25-069599","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Jeff Kutz resigns as CAO; Steve Dassing appointed Principal Accounting Officer at Quaker Chemical","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeff Kutz resigned as Chief Accounting Officer effective July 18, 2025; departure voluntary, no disagreement with Company.","Steve Dassing, 39, assumes Principal Accounting Officer role in addition to his current VP, Corporate Controller position.","Dassing's salary set at $300,000/year; eligible for AIP with 35% target and LTIP with $110,000 target.","Dassing joined Quaker in 2022 as Corporate Controller; prior roles at FXI and Dorman Products; CPA.","No arrangements or family relationships exist between Dassing and any director or executive officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166435,"accession_number":"0000081362-25-000067","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Ramaswami Seshasayee retires from Quaker Chemical board; size reduced to 11","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ramaswami Seshasayee retired from the Board effective May 14, 2025, after serving since 2019.","He was a member of Audit and Compensation Committees; retirement was voluntary with no disagreement with the Company.","Board size reduced from twelve to eleven directors effective immediately upon his retirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166434,"accession_number":"0000081362-25-000061","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Quaker Chemical shareholders elect four directors, approve executive compensation and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors elected: Mark A. Douglas, Sanjay Hinduja, William H. Osborne, Fay West (three-year terms).","Advisory vote on named executive officer compensation approved: 15,656,914 for, 559,078 against.","Ratification of PwC as independent auditor for FY2025 approved: 16,443,533 for, 235,558 against.","Record date March 4, 2025; 17,670,915 shares outstanding; broker non-votes: 457,892."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166433,"accession_number":"0000081362-25-000056","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q1 revenue down 6% to $442.9M; non-GAAP EPS $1.58 vs $2.09; 2025 outlook in-line with 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $442.9M, down 6% YoY; net income $12.9M ($0.73 diluted) vs $35.2M ($1.95) in Q1 2024.","Non-GAAP net income $28.0M, or $1.58 per diluted share, vs $37.7M ($2.09) prior year.","Adjusted EBITDA $69.0M (15.6% margin) vs $83.3M in Q1 2024, down 17% on lower volumes.","Acquired Dipsol Chemicals ($155.2M), Natech ($6.5M), and CSI ($3.9M) to strengthen portfolio.","Guidance: expects 2025 revenue and earnings in-line with 2024; soft end markets persist into H2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":442914000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166432,"accession_number":"0001104659-25-031707","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quaker Houghton closes two acquisitions: Dipsol ($153M) and Natech ($5.2M)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed acquisition of Dipsol Chemicals for 23B JPY (~$153M); multiple ~10.5x trailing EBITDA of ~$15M.","Dipsol had ~$82M revenue for trailing twelve months ending Dec 31, 2024.","Also acquired Natech, Ltd. for ~£4M (~$5.2M), a U.K. surface treatment chemicals manufacturer.","Both deals funded with borrowings under existing credit facility.","CEO cites strategic investments to accelerate growth and cross-sell opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183870,"accession_number":"0001104659-25-028760","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quaker Houghton acquires Dipsol Chemicals for ~$153M (23B JPY) to expand advanced solutions","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price ~$153M (23B JPY); ~10.5x Dipsol's trailing 12-month adjusted EBITDA of ~$15M.","Dipsol had ~$82M revenue over trailing 12 months; ~450 employees globally.","Deal expected to close in Q2 2025, subject to regulatory approvals; funded via existing credit facility.","Acquisition adds surface treatment and plating technologies for automotive and industrial markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183869,"accession_number":"0000081362-25-000012","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q4 net sales down 5% to $444M; adj. EPS drops to $1.33","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $444.1M, down 5% YoY; net income $14.2M ($0.81 diluted EPS) vs $20.2M ($1.12) prior year.","Non-GAAP EPS $1.33 vs $1.78; adjusted EBITDA $64.8M vs $77.0M, down 16%.","Full year net sales $1.84B, net income $116.6M ($6.51 EPS); operating cash flow $204.6M.","Americas segment sales down 8%; EMEA down 7%; Asia/Pacific up 5% on new business wins.","Company expects at least $20M cost savings in 2025 and revenue, EBITDA, earnings growth."],"consensus_eps_estimate":null,"consensus_eps_actual":6.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":1839686000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200471,"accession_number":"0001104659-24-129388","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quaker Chemical awards 5,565 RSUs to CFO Tom Coler and 4,255 RSUs to CSO Jeewat Bijlani","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Target RSU awards: Tom Coler (CFO) 5,565 RSUs, Jeewat Bijlani (CSO) 4,255 RSUs.","Awards are time-based RSUs with performance modifier based on relative TSR vs S&P 1500 Chemicals Index over 3 years (Dec 2024-Dec 2027).","Vesting at 75%-125% of target depending on TSR percentile rank (≤25th percentile => -25%, ≥75th percentile => +25%).","Vesting contingent on continued employment through Dec 15, 2027, with prorated vesting for death, disability, or termination without cause.","Dividend equivalents credited as additional RSUs during vesting period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200470,"accession_number":"0001104659-24-127631","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quaker Chemical finalizes CEO Tometich's severance; 18 months pay, accelerated equity vesting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tometich departed Nov 18, 2024; agreement signed Dec 5, 2024 includes 18 months bi-weekly severance at current rate plus prorated AIP at 100% individual target.","Receives accelerated prorated vesting of outstanding stock options, RSUs, PSUs, and restricted stock under 2016 LTIP; PSUs paid at end of performance periods.","Vested stock options exercisable until earlier of 3rd anniversary of separation or option term.","Also receives 90 days paid salary in lieu of notice, 12 months outplacement, and prorated 2024 AIP bonus in March 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200469,"accession_number":"0001104659-24-125545","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Quaker Houghton's SVP & Chief HR Officer Melissa Leneis departs Dec 2, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Melissa Leneis no longer serves as SVP & Chief HR Officer as of December 2, 2024.","Departure is an involuntary termination without cause; no disagreement with the company.","Leneis will receive severance payments and benefits per her employment agreement and company plans.","No replacement for the Chief HR Officer role has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200468,"accession_number":"0001104659-24-121066","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-11-20T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Quaker Houghton appoints Joseph Berquist as CEO, replacing Andy Tometich","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph Berquist appointed CEO and President effective Nov 18, 2024; also elected to Board as Class I director.","Berquist previously served as Chief Commercial Officer and has been with the company since 1997.","Andy Tometich departs as CEO and President; termination is involuntary without cause, not related to any disagreement.","Berquist's employment agreement: base salary $800K, target bonus 100% of salary, LTI target $2.3M.","Berquist co-led integration of 2019 Quaker Houghton combination and has been involved in 24 acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200467,"accession_number":"0000081362-24-000132","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q3 net sales down 6% to $462.3M; non-GAAP EPS $1.89 vs $2.05","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $462.3M, down 6% YoY; net income $32.3M ($1.81 diluted EPS) from $33.7M ($1.87).","Non-GAAP net income $34.0M, non-GAAP EPS $1.89 vs $2.05; adjusted EBITDA $78.6M (17.0% margin).","Americas net sales $220.3M (-10% YoY) driven by volume and pricing headwinds; EMEA $134.1M (-4%); Asia/Pacific $107.9M (+3%).","Management expects soft market conditions to persist through year-end; focusing on cost discipline and new business wins."],"consensus_eps_estimate":null,"consensus_eps_actual":5.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":1395600000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216500,"accession_number":"0000081362-24-000117","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Houghton Q2 net sales $463.6M (-6%); EPS $1.94; adj. EPS $2.13; EBITDA up 5%; dividend +6.6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $463.6M, down 6% YoY due to index-based pricing (-4%) and slight volume decline (-1%).","GAAP EPS $1.94 vs $1.63; non-GAAP EPS $2.13 vs $1.93; adjusted EBITDA $84.3M, +5% YoY.","Gross margins improved 200 bps YoY, 8th consecutive quarterly increase; operating margins up in all segments.","Americas sales -12% YoY, EMEA -4%, Asia/Pacific +3% on volume improvement and new business wins.","Declared 6.6% dividend increase; repurchased $7.8M in shares; net debt/EBITDA 1.7x."],"consensus_eps_estimate":null,"consensus_eps_actual":3.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":933326000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216499,"accession_number":"0000081362-24-000106","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Quaker Houghton appoints Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 10 to 12 directors; both appointed as independent members effective July 31, 2024.","Bakhshi, former President/CEO of Bank of the West, appointed to Audit and Sustainability Committees.","Foufopoulos-De Ridder, former EVP at Borealis Group, appointed to Compensation & HR and Sustainability Committees.","Compensation follows standard non-employee director program (annual cash retainer + RSUs) as disclosed in 2024 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236126,"accession_number":"0001104659-24-059139","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Quaker Houghton appoints Tom Coler as CFO effective June 10, 2024; Shane Hostetter departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shane Hostetter terminated as CFO effective June 7, 2024; will remain in transition role through August 4, 2024.","Tom Coler appointed EVP and CFO effective June 10, 2024; previously CFO at Savage Companies and H.B. Fuller.","Compensation includes $515k base salary, 65% target annual bonus, $850k target LTI (60% PSUs, 40% RSUs).","Equity sign-on award of $400k RSUs vests on 2nd anniversary; repayment required if voluntary resignation within 3 years.","Relocation lump sum of ~$12,000 grossed up for taxes; temporary housing provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236125,"accession_number":"0000081362-24-000061","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve 2024 Long-Term Performance Incentive Plan, adding 900K shares for equity awards","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restated Plan approved with ~12.8M For, ~3.3M Against; adds 900K shares to share pool (plus remaining 2016 Plan shares).","Three directors re-elected: Michael F. Barry, Jeffry D. Frisby, Russell R. Shaller.","Non-binding advisory vote on executive compensation approved (16.1M For).","Ratification of PricewaterhouseCoopers as auditor for FY 2024 approved (16.8M For)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236124,"accession_number":"0000081362-24-000057","cik":81362,"company_name":"QUAKER CHEMICAL CORP","ticker":"KWR","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quaker Chemical (KWR) Q1 2024 net sales $469.8M (-6% YoY); adj. EBITDA up 6% to $83.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $1.95 vs $1.64 prior year; non-GAAP EPS $2.09 vs $1.89.","Net sales $469.8M, down 6% YoY driven by price/mix (-5%) and volumes (-1%); Asia/Pacific volumes up double-digits.","Gross margin improved 400 bps YoY (7th consecutive quarterly increase).","Adjusted EBITDA $83.3M (+6% YoY); operating cash flow $27.2M vs $37.8M.","Net debt $573.8M, leverage ~1.8x; management confident in volume and earnings growth for 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":1.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":469759000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2557556089.9752893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}